Ando S, Ando S, Otani N, Kanbe T
Dept. of Internal Medicine, Narita Memorial Hospital.
Gan To Kagaku Ryoho. 1993 Jan;20(1):153-6.
A 59-year-old man was admitted to our hospital on May 17, 1991 because of dizziness and a sense of abdominal fullness. Physical examination on admission showed splenomegaly without hepatomegaly or lymphadenopathy, and blood examination revealed normocytic anemia, thrombocytopenia and marked leukocytosis of 16,800/microliters with 87% lymphoid cells. Prolymphocytoid cells formed 28% of the lymphoid cells. Bone marrow aspiration revealed massive infiltration of lymphoid cells. Surface marker analysis showed that the lymphoid cells were positive for anti-HLA-DR, CD 5, CD19, CD20, CD21, SmIgM and SmIgD. The patient was diagnosed as having B-CLL/PL, according to the classification advocated by Melo in 1986, and initially treated with vindesine + prednisolone + pirarubicin (VP-THP). However, the prolymphocyte count increased, so we changed to VP-THP + cyclophosphamide (VEP-THP), and remission was obtained. CLL/PL is a rare disease in Japan but we obtained a good response to chemotherapy.
一名59岁男性因头晕和腹部胀满于1991年5月17日入院。入院时体格检查发现脾脏肿大,无肝脏肿大或淋巴结病,血液检查显示正细胞性贫血、血小板减少,白细胞显著增多,达16,800/微升,其中87%为淋巴细胞。原淋巴细胞样细胞占淋巴细胞的28%。骨髓穿刺显示淋巴细胞大量浸润。表面标志物分析显示淋巴细胞抗HLA - DR、CD5、CD19、CD20、CD21、SmIgM和SmIgD呈阳性。根据1986年Melo提出的分类,该患者被诊断为B - CLL/PL,最初接受长春地辛 + 泼尼松龙 + 吡柔比星(VP - THP)治疗。然而,原淋巴细胞计数增加,因此我们改为VP - THP + 环磷酰胺(VEP - THP)治疗,并获得缓解。CLL/PL在日本是一种罕见疾病,但我们的化疗取得了良好疗效。